MDSAP Readiness, Review, and Remediation
The Medical Device Single Audit Program (MDSAP) allows a single quality system audit to satisfy regulatory expectations across multiple participating regulatory authorities. For manufacturers distributing devices internationally, MDSAP has become a central component of regulatory strategy and market access.
An MDSAP audit evaluates whether a manufacturer’s quality management system consistently supports safe and effective medical device development and lifecycle management across multiple regulatory jurisdictions.
Unlike traditional quality audits, MDSAP follows a structured audit model that examines interconnected processes such as management oversight, design and development controls, supplier management, post-market surveillance, and adverse event reporting.
Frelong Health helps organizations evaluate and strengthen their quality systems so they can withstand the structured scrutiny of an MDSAP audit.
MDSAP Readiness Assessment
We conduct structured readiness reviews based on the MDSAP audit model to determine whether an organization’s existing quality system can support a successful audit.
This includes evaluating core quality system processes such as design controls, supplier management, complaint handling, and regulatory reporting to determine whether documentation and operational practices align with audit expectations.
Process Alignment with the MDSAP Audit Model
The MDSAP audit model evaluates seven interconnected processes that collectively demonstrate regulatory control of medical device development and lifecycle management.
Frelong Health helps organizations align their procedures and documentation with these audit expectations so that quality system processes are clearly defined, consistently implemented, and capable of supporting audit review.
These processes operate within quality systems aligned with standards such as ISO 13485 and are recognized by regulators participating in the Medical Device Single Audit Program.
Gap Analysis and Remediation
When gaps are identified, we work with organizations to strengthen the documentation and operational processes needed to support audit readiness.
This may include improvements to supplier control procedures, post-market surveillance processes, complaint handling workflows, or documentation supporting design and development controls.
The objective is to ensure that quality system processes are both operationally effective and clearly documented for audit review.
Audit Preparation Support
As organizations approach an MDSAP audit, preparation becomes critical. Frelong Health assists teams in reviewing documentation, clarifying process ownership, and ensuring teams understand how quality system processes operate in practice.
This preparation helps organizations approach audits with confidence and reduces the likelihood of findings that can delay market access or require extensive remediation.
Result
Organizations gain a quality management system that not only supports regulatory compliance but also demonstrates operational control across the interconnected processes evaluated during an MDSAP audit.
Frequently Asked Questions
Common questions about MDSAP audits, quality system readiness, process alignment, and remediation for regulated medical device organizations.
-
The Medical Device Single Audit Program (MDSAP) allows a single quality system audit to satisfy regulatory requirements across multiple countries, including the U.S., Canada, Brazil, Australia, and Japan. It is often required for market access and ongoing regulatory compliance.
-
An MDSAP audit evaluates interconnected quality system processes, including management responsibility, design and development, supplier controls, complaint handling, and post-market surveillance. The audit follows a structured process-based model.
-
While ISO 13485 audits focus on quality system compliance, MDSAP audits assess how processes operate together across regulatory jurisdictions. They place greater emphasis on process interactions, regulatory reporting, and lifecycle control.
-
Common findings include gaps in supplier controls, inconsistent complaint handling, weak post-market surveillance processes, and incomplete linkage between design controls and risk management activities.
-
Preparation involves aligning procedures with the MDSAP audit model, ensuring documentation is complete and traceable, and confirming that teams understand how processes operate in practice. A structured readiness assessment is typically recommended before the audit.
-
If gaps are identified, organizations may receive nonconformities that require corrective action and follow-up review. Addressing gaps quickly and systematically is critical to maintaining market access and regulatory standing.
Common Questions by Service
How do I build an ISO 13485-compliant QMS for digital health?
Structured QMS systems must align documentation, risk management, and lifecycle controls from the start.
Explore QMS Systems
What should be included in a Design History File (DHF)?
A defensible DHF connects requirements, risk controls, and verification evidence into a traceable system.
View DHF Review Services
How should software be developed in a regulated digital health environment?
Software must be developed within a controlled lifecycle aligned to IEC 62304, with structured requirements, traceability, risk integration, and verification activities.
Explore Software Development
What does a risk-based verification and validation strategy look like?
Testing must align to risk, ensuring hazards are controlled and verification evidence is defensible.
Explore V&V Advisory
How do I address cybersecurity in regulated medical software?
Cybersecurity requires structured threat modeling, risk controls, and ongoing monitoring aligned to FDA expectations.
Learn About Cybersecurity Compliance
How should CAPA investigations be structured in a regulated QMS?
CAPA investigations must demonstrate clear root cause analysis, risk evaluation, and defensible corrective actions aligned to regulatory expectations.
Explore CAPA Engine
A strong 510(k) requires structured documentation, clear substantial equivalence, and defensible verification and validation evidence.
View 510(k) Strategy & Submission
Make it stand out.
-
Define it.
Every regulated product begins with a concept.
A new device. A new algorithm. A new way to support clinical decisions.
But in regulated healthcare, innovation alone is not enough. Teams must define the regulatory pathway, intended use, system boundaries, and risk posture that will guide development.
Frelong Health works with companies to translate early technical vision into a clear regulatory and development strategy, one that regulators, auditors, and partners can understand from the beginning.
-
Structure it.
Innovation must be supported by structure.
Design controls, risk management, lifecycle traceability, verification planning, and cybersecurity expectations all form the foundation of a compliant system.
Frelong Health helps organizations structure their quality systems, development documentation, and regulatory evidence into a coherent framework aligned with standards such as ISO 13485 and IEC 62304.
The result is not just documentation, it is a working regulatory architecture that supports development rather than slowing it down.
-
Ace it.
Regulators do not evaluate intentions.
They evaluate evidence.
Submissions, audits, and inspections examine whether your development process, risk controls, and documentation can withstand regulatory scrutiny from authorities such as the U.S. Food and Drug Administration and Health Canada.
Frelong Health helps companies strengthen their documentation, resolve gaps, and prepare their systems to stand up to regulatory review, audit, and market authorization processes.